BioSpace News Archive

Biotech Beach

A2 Bio Identifying Solid Tumor Patients for Possible Inclusion in Phase 1 Studies Targeting CEA and Mesothelin Expected to Begin in 2023: Update at SITC 2022

A2 Bio today announced four poster presentations will be given on November 10, 2022 at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting in Boston, MA.

November 7, 2022
·
4 min read
BioForest

Affini-T Therapeutics to Present Preclinical Data from its Lead Programs Targeting KRAS G12V at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

Affini-T Therapeutics to Present Preclinical Data from its Lead Programs Targeting KRAS G12V at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting.

November 7, 2022
·
2 min read
Biotech Bay

AviClear™ Now Broadly Available to US Physicians and Practitioners Upon National Launch

Cutera, Inc., a leading provider of aesthetic and dermatology solutions, announces that AviClear is now broadly available to physicians and practitioners treating patients throughout North America.

November 7, 2022
·
2 min read
Aphaia Pharma to Participate in the LSX Leaders Inv€$tival Showcase

Aphaia Pharma announced that it will participate in the LSX Leaders Inv€$tival Showcase, to be held November 14, 2022, in London as the pre-day to the Jefferies London Healthcare Conference, November 15-17, 2022.

November 7, 2022
·
1 min read
Business

Theralink® Technologies Appoints Dr. Mattia Cremona as its Director of its Biopharma Laboratory

Theralink Technologies, Inc. announced that it has appointed Dr. Mattia Cremona as its Director of its Biopharma Laboratory effective November 7, 2022.

November 7, 2022
·
4 min read
Genetown

Obsidian Therapeutics to Present Preclinical Data from cytoDRiVE® Platform and Pipeline at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2022

Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced it will present preclinical data highlighting its recent cytoDRiVE® platform and pipeline advances during the poster sessions at the upcoming SITC Annual Meeting 2022.

November 7, 2022
·
5 min read
Pharm Country

Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference

Schrödinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered, announced that management will participate in a fireside chat at the Jefferies 13th Annual London Healthcare Conference in London, UK.

November 7, 2022
·
1 min read
Business

UPDATE -- Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

Ikena Oncology, Inc., a targeted oncology company forging new territory in patient-directed cancer treatment, announced financial results for the third quarter ended September 30, 2022.

November 7, 2022
·
10 min read
Business

Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the third quarter ended September 30, 2022 and provided a clinical update on its Phase 3 clinical program of simufilam in Alzheimer’s disease.

November 7, 2022
·
10 min read
Business

Novan to Report Third Quarter 2022 Financial Results on November 14, 2022

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its third quarter 2022 financial results on Monday, November 14th.

November 7, 2022
·
1 min read